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Available online 8 May 2016Background: Porphyromonas gingivalis (P. gingivalis) is known as the main pathogen to progress periodontitis.
The aim of this study was to clarify oral infection P. gingivalis in patients with coronary computed tomography
angiography (CTA) diagnoses.
Methods: The subjectswere 50 consecutive patientswhowere examined by coronary CTA. Their salivawas examined
for thepresence of P. gingivalisby16S rRNA-basedpolymerase chain reaction. The subjectswere divided into3 groups:
normal coronary artery (group NC), patients with coronary plaque but without history of acute coronary syndrome
(ACS) (group CP), and post-ACS (group pACS) according to their ﬁndings on CT and medical history. We assessed
coronary risk factors and C-reactive protein (CRP) levels. Their medical records for the last 5 years were analyzed.
Results: P. gingivalis infection was observed in 37.5% NC (N= 16), 65.2% of the CP (N = 23), and 90.9% of the pACS
patients (N = 11). CRP levels in patients with P. gingivalis infection were higher than in those without the infection
(0.22 ± 0.30 vs 0.07 ± 0.10 mg/dL; p = 0.031). Multiple regression analysis revealed that P. gingivalis (p = 0.047)
was statistically correlated with coronary artery disease (CAD), as well as other coronary risk factors. The patients
with a P. gingivalis infection exhibited lower event free survival ratio (p = 0.0348).
Conclusions: P. gingivaliswas identiﬁed by sensitive detection in patients with CAD, diagnosed by coronary CTA.
P. gingivalis in oral saliva can be a potential marker which is associated with clinical outcomes in patients with CAD.





Periodontitis causes chronic inﬂammation owing to the persistent
activity of dental plaque bacteria in the oral cavity. Among the several
periodontal pathogens (or periodontopathic bacteria), Porphyromonas
gingivalis (P. gingivalis) is well known for destructing periodontal tissue
and progressing periodontitis [1]. In fact, the periodontitis caused by
P. gingivalis could become a risk factor of cardiovascular disease (CVD)
[2]. Holmlund et al. reported that the level of IgG antibodies against
P. gingivalis was increased in patients with myocardial infarction [3].
Therefore, assessing the clinical risk of oral infection with P. gingivalis
is important in patients with coronary artery disease (CAD).
Cardiovascular imaging modalities have progressed remarkably.
One of the developments has beenmultidetector row computed tomog-
raphy (MDCT). The utility of coronary CT angiography (CTA) by usingarMedicine, TokyoMedical and
3-8519, Japan.
land Ltd. This is an open access articlMDCT with electrocardiography (ECG) gating has been established to
visualize coronary artery plaque and its progression [4]. Using this
modality, atherosclerotic lesions are classiﬁed as noncalciﬁed plaque,
calciﬁed lesions, and mixed plaque. These images of coronary athero-
sclerosis signify that it has been possible to stratify CAD patients before
myocardial infarction occurs [5].
The aim of this study was to clarify the incidence of oral infection
P. gingivalis in patients with coronary CTA diagnoses. Additionally, we
assessed the association among the existence of P. gingivalis, coronary
risk factors, and the chronic inﬂammation evaluated by C-reactive
protein (CRP) levels. Finally, we assessed the outcome in patients with
P. gingivalis for 5-years.2. Methods
2.1. Study population
The study population consisted of 50 consecutive patients at the
Department of Cardiovascular Medicine, Tokyo Medical and Dentale under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Table 1
Species-speciﬁc and ubiquitous primers for PCR.










Number and rate of oral
P. gingivalis infection
LAD 30 (60%) 21 (70%)
LCX 22 (44%) 15 (68.2%)
RCA 22 (44%) 17 (77.3%)
Normal coronary 16 (32%) 6 (37.5%)
1 vessel 11 (22%) 9 (81.8%)
2 vessels 6 (12%) 4 (66.7%)
3 vessels 17 (34%) 12 (70.6%)
8 D. Tezuka et al. / IJC Metabolic & Endocrine 11 (2016) 7–12University (TMDU) in 2008. Saliva samples were obtained from all pa-
tients prior to undergoing a coronary CTA scan. The patients received
a coronary CTA scan because of chest complaints, ECG abnormalities,
or follow-up percutaneous coronary intervention (PCI). All patients
were divided into the following 3 groups according to the ﬁndings
from their coronary CTA and medical history: normal coronary artery
(NC), coronary plaque on the CT but without history of acute coronary
syndrome (CP), and post-acute coronary syndrome (pACS). Group NC
included patients with no coronary plaque on the coronary CTA.
Group CP included patients showing asymptomatic or symptomatic pa-
tients showing coronary plaque on the imaging. Group pACS included
patients who had ACS in past records and showed coronary plaque on
CT in this study. Informed consent was obtained from each subject
after providing verbal and written explanations. The medical records
of all patients were reviewed to determine whether they had obesity
(body mass index N 25 kg/m2), a smoking habit, a family history of
CAD, and a prescription for medicine to treat hypertension (HT), diabe-
tes mellitus (DM), hyperlipidemia (HL) and chronic kidney disease
(CKD). The level of C-reactive protein (CRP) was also determined in
their medical records. CRP levels were obtained on the closest day to
the coronary CTA examination. All objective patients were deﬁned as
not in another infectious stage and conﬁrmed by medical records. The
study was approved by the Ethics Committee of Tokyo Medical and
Dental University (approved number, 469).
2.2. Coronary CTA examination
ECG-gated coronary CTA was performed using 64-MDCT (Aquilion,
ToshibaMedical, Tokyo, Japan) at TokyoMedical and Dental University.
Before scanning, nitroglycerin was sprayed into the patient's mouth to
dilate the coronary artery. All imaging data were obtained during expi-
ratory breath-holding. Iopamidol was used as the contrast medium, and
was injected at 4 mL/s by an auto-injector. The volume of contrast me-
diumwas decided according to the patient's bodyweight. Imaging data
with contrast medium was obtained by using a 0.5-mm slice. It was
used to be reconstructed to assess a stenotic lesion in a coronary artery.
2.3. Analysis of coronary CTA after the reconstruction
Ziostation (Ziosoft, Inc., Tokyo) was used to reconstruct and analyze
coronary CTA data. Agatston score was calculated using this software.
The characteristics of coronary plaque were assessed based on a
multicurved planner reconstruction view and a cross section view. The
plaques were diagnosed according to the following classiﬁcation;
noncalciﬁed plaques, mixed plaques, and calciﬁed plaques.
2.4. Sample collection and preparation
Saliva samples (500 μL) were collected in sterile tubes, diluted with
puriﬁedwater, and centrifuged at 3000 rpm× 5min. The sedimentwas
diluted with puriﬁed water, and centrifuged at 3000 rpm × 5 min. This
procedurewas repeated 5 times and the sampleswere stored at−80 °C
until analysis.
2.5. Polymerase chain reaction for the detection of periodontopathogen
The saliva samples were analyzed by 16S rRNA-based polymerase
chain reaction (PCR) detection method [6] to determine the presence
of P. gingivalis. The 16S rRNA-speciﬁc primers used are shown in
Table 1. Brieﬂy, each 50-μL PCR reaction mixture contained 5 μL of the
sample, 5 μL of 10× PCR buffer (Takara, Shiga, Japan), 1.25 units of Taq
DNA polymerase (Takara), 0.2 mM of each deoxyribonucleotide
(Takara), 1.0 mM of each primer, and 1.5 mM MgCl2 for detecting
P. gingivalis infection. PCR ampliﬁcation was performed in a DNA ther-
mal cycler (PTC-200; MJ Research, Boston, MA). The PCR temperature
proﬁle for P. gingivalis included an initiation step at 95 °C for 2 min;followed by 36 cycles at 95 °C for 30 s, 60 °C for 1 m, and 72 °C for
1 min; and a ﬁnal step at 72 °C for 2 min. PCR ampliﬁcation products
were analyzed with 1.0% agarose gel electrophoresis. The gel was
stained with 0.01 mg/L ethidium bromide and photographed under
ultraviolet light at 300 nm. A 100 bp DNA ladder digest (Promega,
Madison, WI) served as the molecular size marker.
2.6. Culture of microorganisms
For use as a control, P. gingivalis 381 was grown in brain heart
infusion (BHI) broth (Difco) supplemented with vitamin K and hemin
under anaerobic conditions (10%H2, 5% CO2, and 85%N2) and harvested
after 5 days. The microorganism was harvested by centrifugation,
washed 3 times with distilled water, and lyophilized. Sonicated whole
cell extracts of periodontopathogens were prepared according to
the method of Naito and coworkers [7]. Cells were suspended in
saline (200 mg/mL, wet weight) and disrupted by sonication on ice at
30-s intervals for a total sonication time of 3 min at maximum output.
The sonicated cell suspensions were centrifuged and the supernatants
were lyophilized.
2.7. Multiple logistic regression analysis
Multiple logistic regression analysiswas used to analyze the conven-
tional coronary risk factors (obesity, HT, DM,HL, family history, smoking
and CKD) and P. gingivalis infection in patients with CAD.
2.8. Event free survival ratio during the 5-year observation period
The Kaplan–Meier curve was used to assess the clinical outcome of
all patients prospectively for 5 years. A clinical event was deﬁned as
all cause-mortality or requiring intervention by PCI or coronary artery
bypass graft.
2.9. Statistical analysis
Categorical data are presented as numbers (percentages), and
continuous data are presented as means ± standard deviation of
the mean (SDM). Nonparametric statistical analysis by the Mann–
Whitney–Wilcoxon test was used to compare 2 groups. For the com-
parison of 3 groups, one-way analysis of variance (ANOVA) with
Bonferroni adjustment was performed. The 95% conﬁdence intervals
were calculated, and a value of p b 0.05 was considered statistically
signiﬁcant. The statistical difference of the Kaplan–Meier curve
was assessed by log-rank test. Statistical analysis, including themultiple
Fig. 1. Comparison of Agatston scores and detection of P. gingivalis among the NC, CP, and pACS groups. Left; Agatston scorewas signiﬁcantly different among the NC, CP and pACS groups.
Right; the detection rates of P. gingivalis in oral saliva increased in the CP and pACS group. P. gingivalis: Porphyromonas gingivalis, NC: normal coronary artery, CP: coronary plaque, pACS:
post-acute coronary syndrome.
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software (SPSS Inc., Chicago).3. Results
The background of the lesions on coronary CTA and oral P. gingivalis
infection is presented in Table 2. Coronary CTA analysis revealed that
Agatston score was statistically different among the 3 groups (pACS
(N = 11), 749.2 ± 1028.1; vs CP (N = 23), 558.8 ± 804.8; vs NC
(N = 16), 0; p b 0.001) (Fig. 1, left). The representative bands of PCR
in the ﬁrst 10 cases of this study are presented in Fig. 2. In the oral saliva
bands, P. gingivaliswas observed in 62% (31 cases) of the whole objec-
tive cases. P. gingivalis had the highest prevalence in the pACS group
among the 3 groups (pACS, 90.9% vs CP, 65.2% vs NC 37.5%; p =
0.019) (Fig. 1 right).
SerumCRP levelsweremeasured in 48 cases. All patientswere not in
a systemic infectious stage. CRP levels had statistical difference amongFig. 2. Thedetection of P. gingivalisby PCR examination. Theﬁrst representative 10 cases are sho
the positive control. P. gingivalis: Porphyromonas gingivalis.the 3 groups (NC, 0.06 ± 0.06 vs CP, 0.21 ± 0.24 mg/dL vs pACS,
0.24 ± 0.38 mg/dL, p = 0.019) (Fig. 3 left).
The clinical characteristics of patientswith orwithout P. gingivalis in-
fection are shown in Table 3. Individuals with P. gingivalis infection
more frequently had CAD compared with those without P. gingivalis
(P. gingivalis (+); 83.9% vs P. gingivalis (−); 47.4%, p = 0.007). There
was no statistical difference in coronary risk factors between the
two groups except for HL. CRP levels in P. gingivalis infected cases
were signiﬁcantly higher than those without P. gingivalis infection
(0.22 ± 0.30 vs 0.07 ± 0.10 mg/dL; p = 0.031) (Fig. 3 right).
On the multiple logistic regression analysis, P. gingivalis infection
(p = 0.047), obesity (p = 0.037), DM (p = 0.005), HL (p = 0.005),
family history (p = 0.036) and CKD (p = 0.031) were regarded as the
correlated factor of CAD in these case series (Table 4).
The Kaplan–Meier curve demonstrated that the prognosis of
patients with P. gingivalis in oral saliva was worse than in patients
without P. gingivalis (p = 0.0348) (Fig. 4 left). There was no signiﬁcant
difference amongNC, CP and pACS in the curves (p=0.4634, n.s) (Fig. 4wn. The P. gingivalisbandwas obtained from the case number 1, 2, 3, 5, 6, 7, and 9, aswell as
Fig. 3.Comparison of CRP levels. Left: the CRP levels statistically different among theNC, CP and pACS groups. Right: the CRP level in caseswith P. gingivalis infectionwas statistically higher
than that in those without P. gingivalis infection. CRP: C-reactive protein, NC: normal coronary artery, CP: coronary plaque, pACS: post-acute coronary syndrome, P. gingivalis:
Porphyromonas gingivalis.
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group of CP and pACS in the curves (p = 0.2532, n.s) (Fig. 4 middle).
The representative case was presented in Fig. 5.
4. Discussion
Previous epidemiologic studies of CAD have clariﬁed the role of cor-
onary risk factors in preventive medicine [8]. However, periodontitis
has not been recognized as a coronary risk factor, despite many studies
showing a relationship between periodontitis and CAD [9–11]. The pur-
pose of this studywas to determine the association between P. gingivalis
and patients with CAD, which was diagnosed by coronary CTA. The
methods of past studies could potentially include CAD patients without
any symptoms as ‘normal controls’. However, coronary CTA is useful to
identify the morphology of coronary plaque, even in asymptomatic
patients with CAD.
In the pathological dynamics of atherosclerosis in the coronary arte-
rial wall, some triggers caused by inﬂammation within atheromatous
plaque leads to its destabilization, causing acute coronary syndrome
[12]. On the other hand, dental plaque bacteria can also contribute to
this destabilization [13], because the periodontopathic bacteria in the
oral cavity can invade internal systems, passing through the damaged
periodontal tissue. It was reported that P. gingivalis has the potential
capacity of adhesion and invasion to the endothelial cell of coronary ar-
tery in vitro [14]. However, the pathological effect of periodontopathic
bacteria is very complex [2,15]. In addition to the direct response on
the coronary artery, periodontitis causes an indirect response, leading
to systemic inﬂammation by increasing cytokines such as IL-6. It could
also change lipid pooling in the blood circulation [16].
Our data demonstrated a close relationship between CAD and
P. gingivalis. P. gingivalis is rarely observed in the oral cavity of young
and healthy individuals [17]. The bacteria of infected persons couldTable 3
Characteristics of patients.
P. gingivalis (−) P. gingivalis (+) p value
Case number (male) 19 31
Age 63.1 ± 9.6 67.2 ± 7.1 n.s
Sex (%) 63.2 74.2 n.s
Number of CAD patients 9 (47.4%) 26 (83.9%) p = 0.007
Obesity (%) 36.8 54.8 n.s
HT (%) 52.6 67.7 n.s
DM (%) 15.8 35.5 n.s
HL (%) 42.1 71.0 p = 0.045
Smoking (%) 21.1 38.7 n.s
Family history (%) 21.1 16.1 n.s
CKD (%) 15.8 16.1 n.s
Bold values indicate signiﬁcance at p b 0.05.enter the oral cavity of an uninfected one. The bacteria attach itself to
the oral cavity, because the oral cavity presents a variety of surfaces
and consequently, it helps that attachment [2]. P. gingivalis can prolifer-
ate in the oral environment as patients aging and oral cavity condition
shifts from aerobic to anaerobic. In adult individuals, it has been report-
ed that P. gingivaliswas detected in the oral saliva of 54.5% patients with
an aortic aneurysm [18]. On the other hand, the present study demon-
strated that the prevalence of oral P. gingivalis infection was detected
in 73.5% of CAD patients with an elevated level of CRP. Attention to
assess elevation of CRP with regard to interplay of confounding factors
is required, because it is known to be elevated in patients with peri-
odontitis [19] and with CAD [20,21].
In our multiple logistic regression analysis, oral infection of
P. gingivaliswas comparable to the other coronary risk factors associated
with CAD. Our Kaplan–Meier curve demonstrated that the cases with
P. gingivalis infection had worse outcomes than the cases without
P. gingivalis. Thus, this study demonstrates that there is a close correla-
tion or overlapping in patients with CAD and P. gingivalis.
These results imply that oral infection of P. gingivaliswas a potential
marker to estimate clinical prognosis associated with CAD. No other
clinical studies about periodontal disease showed a comparison be-
tween P. gingivalis and severity of atherosclerosis in patients classiﬁed
by coronary CTA for assessing risk stratiﬁcation. Further research is
needed to clarify the association between CAD and the infection of
P. gingivalis.
5. Limitations
The study design was limited as the number of study cases was
relatively low. CRP data was obtained by reviewing medical records.
However, a systemic infectious condition was not observed in any pa-
tients. Multiple regression analysis and the Kaplan Meier curve require
more cases formeaningful statistical analysis, particularly to exclude the
inﬂuence of confounding factors.Table 4
Multiple logistic regression analysis between coronary










Fig. 4. Event-free survival ratio obtained by Kaplan–Meier analysis. Left; the event free survival ratio in the cases with P. gingivalis infection was worse after 5 years of observation. Right;
the KaplanMeier curveswere not different among theNC, CP and pACS groups. Middle; the curves in the NC group comparedwith the CP and pACS groupswere not statistically different.
CP: coronary plaque, NC: normal coronary artery, pACS: post- acute coronary syndrome, P. gingivalis: Porphyromonas gingivalis.
Fig. 5. A representative case. The patient, a 66-year-old man, had a high risk of coronary artery disease due to hypertension, hyperlipidemia, smoking, and chronic kidney disease.
According to his medical record, he had repeated PCI to treat unstable angina pectoris and was classiﬁed as a post-ACS case. On the coronary CT angiography, his Agatston score was
12 and a curved planar reconstruction view showed noncalciﬁed and a spotty calciﬁed plaque. Polymerase chain reaction analysis of his salivary sample revealed a band of P. gingivalis,
which was similar to the positive control band. He underwent PCI 35 months after entry into this study (Fig. 5). MIP: maximum intensity projection, MPR: multi-planar reconstruction,
PCI: percutaneous coronary intervention, ACS: acute coronary syndrome, CT: coronary computed tomography, Pg or P. gingivalis: Porphyromonas gingivalis.
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12 D. Tezuka et al. / IJC Metabolic & Endocrine 11 (2016) 7–12We did not assess blood samples for IgG antibody, which is com-
monly used when detecting an infectious phenomenon. Moreover,
there are some problems in quantitative assessment in IgG antibody
for practical use in clinical situations.
6. Conclusion
P. gingivaliswas frequently identiﬁed in oral saliva in CAD diagnosed
by coronary CTA. Oral infection by P. gingivalis can be used as a coronary
risk factor and a potentialmarkerwhich is associatedwith theprognosis
of CAD patients.
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